SCHEMBL2565220

SCHEMBL2565220

COC1CCCC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6871040 1.00
SCHEMBL6871042 1.00
SCHEMBL883353 1.00
SCHEMBL773316 1.00
SCHEMBL2624944 0.94
SCHEMBL7919630 0.94
SCHEMBL2624942 0.94
SCHEMBL7459109 0.94
SCHEMBL2429552 0.94
SCHEMBL3149007 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118422225-A Preparation method of polysubstituted cyclic ether compound 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) 2024-08-02 CN claimed
EP-3911416-B1 SUBSTITUTED QUINAZOLINES AS NLRP3 MODULATORS, FOR USE IN THE TREATMENT OF CANCER INNATE TUMOR IMMUNITY INC (US) 2024-06-12 EP claimed
CN-118422225-A Preparation method of polysubstituted cyclic ether compound 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) 2024-08-02 CN disclosed
US-20230303564-A1 PYRIMIDINE RING COMPOUND Zhejiang Yangli Pharmaceutical Technology Co., Ltd. (CN) 2023-09-28 US disclosed
US-20230303564-A1 PYRIMIDINE RING COMPOUND Zhejiang Yangli Pharmaceutical Technology Co., Ltd. (CN) 2023-09-28 US disclosed
WO-2015185485-A1 USE OF SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2015-12-10 WO disclosed
US-20140171427-A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-06-19 US disclosed
US-20110306607-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-12-15 US disclosed
EP-2382972-A1 Methods for preventing and treating neurodegenerative disorders Boehringer Ingelheim International GmbH (DE) 2011-11-02 EP disclosed
CN-101130552-B Process for preparing the antiviral agent [1s-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one BRISTOL MYERS SQUIBB CO 2010-07-28 CN disclosed
US-20100081625-A1 METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 US disclosed
EP-0361618-A2 Alkoxylation using modified calcium-containing catalysts UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) 1990-04-04 EP disclosed
EP-0361620-A2 Alkoxylation using modified group IIIB metal-containing bimetallic or polymetallic catalysts UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) 1990-04-04 EP disclosed
EP-0361616-A2 Alkoxylation using modified group IIA metal-containing bimetallic or polymetallic catalysts UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) 1990-04-04 EP disclosed
US-4902658-A Alkoxylation using heterogeneous calcium catalysts and products therefrom UNION CARBIDE CORPORATION (US) 1990-02-20 US disclosed
US-4886917-A EPOXIDES AND FATTY ALCOHOL REACTION PRODUCT MIXTURES UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1989-12-12 US disclosed
US-4820673-A CALCIUM OXIDE OR HYDROXIDE SOLUBILIZED BY ORGANIC ACTIVATORS HAVING OXY, AMINO, SULFUR OR PHOSPHINE GROUPS UOP (US) 1989-04-11 US disclosed
US-4754075-A NARROW MOLECULAR WEIGHT DISTRIBUTION UNION CARBIDE CORPORATION (US) 1988-06-28 US disclosed
EP-0133715-A1 Alkoxylation using calcium catalysts and products therefrom UNION CARBIDE CORPORATION (US) 1985-03-06 EP disclosed
WO-1985000365-A1 ALKOXYLATION USING CALCIUM CATALYSTS AND PRODUCTS THEREFROM UNION CARBIDE CORPORATION (US) 1985-01-31 WO disclosed